Clinical and Pharmacokinetic Factors Associated With Adalimumab-Induced Mucosal Healing in Patients With Crohn's Disease

Medicine & Life Sciences

• Adalimumab 100%
• Crohn Disease 75%
• Pharmacokinetics 59%
• Azathioprine 32%
• Odds Ratio 31%
• Confidence Intervals 29%
• Randomized Controlled Trials 13%
• Biological Products 9%
• Japan 8%
• Data Analysis 7%
• Referral and Consultation 7%